1.Academic Achievement, Self-directed Learning, and Critical Thinking Disposition According to Learning Styles of Nursing Students.
Sunhee YANG ; Eunho HA ; Ogcheol LEE ; Inok SIM ; Youngmi PARK ; Hyuna NAM ; Jeongsook KIM
Journal of Korean Academy of Fundamental Nursing 2012;19(3):334-342
PURPOSE: This descriptive study was done to identify the academic achievement, self-directed learning (SDL), and critical thinking disposition (CTD) of nursing students according to their learning styles. METHOD: The participants were 240 nursing students. Data were collected using structured questionnaires which included Kolb's Learning Style Inventory, Academic Achievement in Fundamental Nursing and Health Assessment, Self Directed Learning Readiness Scale, and California Critical Thinking Disposition Inventory. Data were analyzed using chi2 test, ANOVA, Pearson' correlation coefficients, and Spearman rank correlation coefficient. RESULTS: One third of respondents were shown to be Convergers in their learning style (33.3%). The Academic Achievement of students who were Convergers was significantly higher than those who were Divergers or Accommodators (F=5.95, p=.001). The SDL and CTD of students who were Convergers were significantly higher than Divergers and Assimilators (F=9.67, p<.001 and F=8.42, p<.001). No significant correlations were found between Academic Achievement and SDL or CTD, but a statistically significant positive correlation was found between SDL and CTD (r=.68, p<.001). CONCLUSION: The findings of this study indicate that learning style influences academic achievement, SDL and CTD.
Achievement
;
California
;
Surveys and Questionnaires
;
Humans
;
Learning
;
Self-Assessment
;
Students, Nursing
;
Thinking
2.Direct Reprogramming to Human Induced Neuronal Progenitors from Fibroblasts of Familial and Sporadic Parkinson’s Disease Patients
Minhyung LEE ; Hyuna SIM ; Hyunjun AHN ; Jeongmin HA ; Aruem BAEK ; Young Joo JEON ; Mi Young SON ; Janghwan KIM
International Journal of Stem Cells 2019;12(3):474-483
In Parkinson’s disease (PD) research, human neuroblastoma and immortalized neural cell lines have been widely used as in vitro models. The advancement in the field of reprogramming technology has provided tools for generating patient-specific induced pluripotent stem cells (hiPSCs) as well as human induced neuronal progenitor cells (hiNPCs). These cells have revolutionized the field of disease modeling, especially in neural diseases. Although the direct reprogramming to hiNPCs has several advantages over differentiation after hiPSC reprogramming, such as the time required and the simple procedure, relatively few studies have utilized hiNPCs. Here, we optimized the protocol for hiNPC reprogramming using pluripotency factors and Sendai virus. In addition, we generated hiNPCs of two healthy donors, a sporadic PD patient, and a familial patient with the LRRK2 G2019S mutation (L2GS). The four hiNPC cell lines are highly proliferative, expressed NPC markers, maintained the normal karyotype, and have the differentiation potential of dopaminergic neurons. Importantly, the patient hiNPCs show different apoptotic marker expression. Thus, these hiNPCs, in addition to hiPSCs, are a favorable option to study PD pathology.
Cell Line
;
Dopaminergic Neurons
;
Fibroblasts
;
Humans
;
In Vitro Techniques
;
Induced Pluripotent Stem Cells
;
Karyotype
;
Neuroblastoma
;
Neurons
;
Pathology
;
Sendai virus
;
Stem Cells
;
Tissue Donors
3.Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons
Hyejung KIM ; Hyuna SIM ; Joo-Eun LEE ; Mi Kyoung SEO ; Juhee LIM ; Yeojin BANG ; Daleum NAM ; Seo-Young LEE ; Sun-Ku CHUNG ; Hyun Jin CHOI ; Sung Woo PARK ; Ilhong SON ; Janghwan KIM ; Wongi SEOL
Experimental Neurobiology 2021;30(3):232-243
Mutations in the Leucine-rich repeat kinase 2 (LRRK2 ) gene are the most prevalent cause of familial Parkinson’s disease (PD). The increase in LRRK2 kinase activity observed in the pathogenic G2019S mutation is important for PD development. Several studies have reported that increased LRRK2 kinase activity and treatment with LRRK2 kinase inhibitors decreased and increased ciliogenesis, respectively, in mouse embryonic fibroblasts (MEFs) and retinal pigment epithelium (RPE) cells. In contrast, treatment of SH-SY5Y dopaminergic neuronal cells with PD-causing chemicals increased ciliogenesis. Because these reports were somewhat contradictory, we tested the effect of LRRK2 kinase activity on ciliogenesis in neurons. In SH-SY5Y cells, LRRK2 inhibitor treatment slightly increased ciliogenesis, but serum starvation showed no increase. In rat primary neurons, LRRK2 inhibitor treatment repeatedly showed no significant change. Little difference was observed between primary cortical neurons prepared from wild-type (WT) and G2019S +/- mice. However, a significant increase in ciliogenesis was observed in G2019S +/- compared to WT human fibroblasts, and this pattern was maintained in neural stem cells (NSCs) differentiated from the induced pluripotent stem cells (iPSCs) prepared from the same WT/G2019S fibroblast pair. NSCs differentiated from G2019S and its gene-corrected WT counterpart iPSCs were also used to test ciliogenesis in an isogenic background. The results showed no significant difference between WT and G2019S regardless of kinase inhibitor treatment and B27-deprivation-mimicking serum starvation. These results suggest that LRRK2 kinase activity may be not a direct regulator of ciliogenesis and ciliogenesis varies depending upon the cell type or genetic background.
4.Ciliogenesis is Not Directly Regulated by LRRK2 Kinase Activity in Neurons
Hyejung KIM ; Hyuna SIM ; Joo-Eun LEE ; Mi Kyoung SEO ; Juhee LIM ; Yeojin BANG ; Daleum NAM ; Seo-Young LEE ; Sun-Ku CHUNG ; Hyun Jin CHOI ; Sung Woo PARK ; Ilhong SON ; Janghwan KIM ; Wongi SEOL
Experimental Neurobiology 2021;30(3):232-243
Mutations in the Leucine-rich repeat kinase 2 (LRRK2 ) gene are the most prevalent cause of familial Parkinson’s disease (PD). The increase in LRRK2 kinase activity observed in the pathogenic G2019S mutation is important for PD development. Several studies have reported that increased LRRK2 kinase activity and treatment with LRRK2 kinase inhibitors decreased and increased ciliogenesis, respectively, in mouse embryonic fibroblasts (MEFs) and retinal pigment epithelium (RPE) cells. In contrast, treatment of SH-SY5Y dopaminergic neuronal cells with PD-causing chemicals increased ciliogenesis. Because these reports were somewhat contradictory, we tested the effect of LRRK2 kinase activity on ciliogenesis in neurons. In SH-SY5Y cells, LRRK2 inhibitor treatment slightly increased ciliogenesis, but serum starvation showed no increase. In rat primary neurons, LRRK2 inhibitor treatment repeatedly showed no significant change. Little difference was observed between primary cortical neurons prepared from wild-type (WT) and G2019S +/- mice. However, a significant increase in ciliogenesis was observed in G2019S +/- compared to WT human fibroblasts, and this pattern was maintained in neural stem cells (NSCs) differentiated from the induced pluripotent stem cells (iPSCs) prepared from the same WT/G2019S fibroblast pair. NSCs differentiated from G2019S and its gene-corrected WT counterpart iPSCs were also used to test ciliogenesis in an isogenic background. The results showed no significant difference between WT and G2019S regardless of kinase inhibitor treatment and B27-deprivation-mimicking serum starvation. These results suggest that LRRK2 kinase activity may be not a direct regulator of ciliogenesis and ciliogenesis varies depending upon the cell type or genetic background.